MustGrow Biologics Corp.
MGROF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -91.6% | 72,627.3% | -49.7% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 75.6% | 91.9% | -4,506.9% | -1,484.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -151% | -9.9% | -4,692.1% | -2,191.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,228.3% | -14.4% | -85,908.3% | -23,809.2% |
| EPS Diluted | -0.095 | -0.014 | -0.11 | -0.07 |
| % Growth | -596.3% | 87.6% | -56.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |